======= ATAD1 ======= == Gene Information == * **Official Symbol**: ATAD1 * **Official Name**: ATPase family AAA domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84896|84896]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NBU5|Q8NBU5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ATAD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATAD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614452|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: ATPase that plays a critical role in regulating the surface expression of AMPA receptors (AMPAR), thereby regulating synaptic plasticity and learning and memory. Required for NMDA- stimulated AMPAR internalization and inhibition of GRIA1 and GRIA2 recycling back to the plasma membrane; these activities are ATPase-dependent (By similarity). {ECO:0000250}. |AAA| |negative regulation of synaptic transmission, glutamatergic| |positive regulation of receptor internalization| |positive regulation of receptor-mediated endocytosis| |regulation of receptor internalization| |peroxisomal membrane| |negative regulation of synaptic transmission| |regulation of synaptic transmission, glutamatergic| |positive regulation of endocytosis| |regulation of receptor-mediated endocytosis| |memory| |learning| |postsynaptic membrane| |regulation of endocytosis| |ATPase activity| |learning or memory| |cognition| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |cell junction| |regulation of vesicle-mediated transport| |behavior| |positive regulation of transport| |positive regulation of cellular component organization| |negative regulation of cell communication| |negative regulation of signaling| |nervous system process| |ATP binding| |regulation of transport| |system process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp211|AICAR 240μM R05 exp211]]|1.71| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|1.73| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|1.79| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.79| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|1.89| |[[:results:exp19|Etoposide 1μM R00 exp19]]|2.02| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.35| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.44| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.49| |[[:results:exp135|MS023 7μM R03 exp135]]|2.69| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|3.09| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|3.26| ^Gene^Correlation^ |[[:human genes:a:apaf1|APAF1]]|0.575| |[[:human genes:v:vdac2|VDAC2]]|0.57| |[[:human genes:b:bak1|BAK1]]|0.569| |[[:human genes:d:diablo|DIABLO]]|0.565| |[[:human genes:m:march5|MARCH5]]|0.559| |[[:human genes:u:ubqln1|UBQLN1]]|0.538| |[[:human genes:p:plaa|PLAA]]|0.537| |[[:human genes:c:casp9|CASP9]]|0.524| |[[:human genes:f:faf2|FAF2]]|0.501| |[[:human genes:s:serf2|SERF2]]|0.499| |[[:human genes:c:cycs|CYCS]]|0.485| |[[:human genes:m:mfn1|MFN1]]|0.451| |[[:human genes:g:gabpa|GABPA]]|0.446| |[[:human genes:h:hccs|HCCS]]|0.427| |[[:human genes:d:dohh|DOHH]]|0.426| |[[:human genes:r:romo1|ROMO1]]|0.425| |[[:human genes:h:hspd1|HSPD1]]|0.419| |[[:human genes:e:eny2|ENY2]]|0.407| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10152 * **Expression level (log2 read counts)**: 6.49 {{:chemogenomics:nalm6 dist.png?nolink |}}